Ibiden Co.,Ltd. Just Beat Analyst Forecasts, And Analysts Have Been Updating Their Predictions
Ibiden Co.,Ltd. (TSE:4062) defied analyst predictions to release its first-quarter results, which were ahead of market expectations. IbidenLtd beat earnings, with revenues hitting JP¥123b, ahead of expectations, and statutory earnings per share outperforming analyst reckonings by a solid 19%. This is an important time for investors, as they can track a company's performance in its report, look at what experts are forecasting for next year, and see if there has been any change to expectations for the business. So we collected the latest post-earnings statutory consensus estimates to see what could be in store for next year.
Taking into account the latest results, the current consensus from IbidenLtd's 17 analysts is for revenues of JP¥529.8b in 2027. This would reflect a notable 20% increase on its revenue over the past 12 months. Statutory earnings per share are predicted to climb 10% to JP¥271. Before this earnings report, the analysts had been forecasting revenues of JP¥522.8b and earnings per share (EPS) of JP¥258 in 2027. So the consensus seems to have become somewhat more optimistic on IbidenLtd's earnings potential following these results.
Check out our latest analysis for IbidenLtd
The analysts have been lifting their price targets on the back of the earnings upgrade, with the consensus price target rising 5.9% to JP¥24,288. That's not the only conclusion we can draw from this data however, as some investors also like to consider the spread in estimates when evaluating analyst price targets. There are some variant perceptions on IbidenLtd, with the most bullish analyst valuing it at JP¥30,000 and the most bearish at JP¥10,500 per share. This is a fairly broad spread of estimates, suggesting that analysts are forecasting a wide range of possible outcomes for the business.
Of course, another way to look at these forecasts is to place them into context against the industry itself. The analysts are definitely expecting IbidenLtd's growth to accelerate, with the forecast 27% annualised growth to the end of 2027 ranking favourably alongside historical growth of 0.3% per annum over the past five years. Compare this with other companies in the same industry, which are forecast to grow their revenue 9.6% annually. It seems obvious that, while the growth outlook is brighter than the recent past, the analysts also expect IbidenLtd to grow faster than the wider industry.
The Bottom Line
The most important thing here is that the analysts upgraded their earnings per share estimates, suggesting that there has been a clear increase in optimism towards IbidenLtd following these results. Fortunately, they also reconfirmed their revenue numbers, suggesting that it's tracking in line with expectations. Additionally, our data suggests that revenue is expected to grow faster than the wider industry. There was also a nice increase in the price target, with the analysts clearly feeling that the intrinsic value of the business is improving.
With that said, the long-term trajectory of the company's earnings is a lot more important than next year. We have estimates - from multiple IbidenLtd analysts - going out to 2029, and you can see them free on our platform here.
It is also worth noting that we have found 2 warning signs for IbidenLtd (1 is concerning!) that you need to take into consideration.
Have feedback on this article? Concerned about the content? Get in touch with us directly. Alternatively, email editorial-team (at) simplywallst.com.
This article by Simply Wall St is general in nature. We provide commentary based on historical data and analyst forecasts only using an unbiased methodology and our articles are not intended to be financial advice. It does not constitute a recommendation to buy or sell any stock, and does not take account of your objectives, or your financial situation. We aim to bring you long-term focused analysis driven by fundamental data. Note that our analysis may not factor in the latest price-sensitive company announcements or qualitative material. Simply Wall St has no position in any stocks mentioned.